PubRank

H Lemke

Author PubWeight™ 94.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984 17.76
2 Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983 11.19
3 The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985 6.74
4 Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice. Immunol Rev 1979 4.31
5 Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse. Nature 1978 3.45
6 Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982 3.26
7 Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer 1982 2.51
8 Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 1985 2.35
9 X-ray and optical wave mixing. Nature 2012 1.92
10 Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages. Cell Immunol 1975 1.65
11 Monoclonal antibodies against murine cell surface antigens: anti-H-2, anti-Ia and anti-T cell antibodies. Curr Top Microbiol Immunol 1978 1.55
12 Function of 2-mercaptoethanol as a macrophage substitute in the primary immune response in vitro. J Immunol 1976 1.49
13 Evidence for the detection of the normal counterpart of Hodgkin and Sternberg-Reed cells. Hematol Oncol 1984 1.47
14 Biochemical characterization of a factor released by macrophages. Cell Immunol 1975 1.44
15 Single shot spatial and temporal coherence properties of the SLAC Linac Coherent Light Source in the hard x-ray regime. Phys Rev Lett 2012 1.32
16 Isolation of a cloned cell line expressing variant H-2Kk using fluorescence-activated cell sorting. Nature 1981 1.23
17 The role of adherent cells in the immune response. Fibroblasts and products released by fibroblasts and peritoneal cells can substitute for adherent cells. Scand J Immunol 1976 1.21
18 Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines. J Immunol 1987 1.13
19 Inhibition of killer-target cell interaction by monoclonal anti-H-2 antibodies. Eur J Immunol 1979 1.05
20 Evidence of Sternberg-Reed cells being derived from activated lymphocytes. Haematol Blood Transfus 1985 1.01
21 High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997 1.00
22 Macrophages suppress direct B-cell activation by lipopolysaccharide. Scand J Immunol 1975 1.00
23 Self-abusive behavior in the mentally retarded. Am J Occup Ther 1974 0.98
24 Activation of T-cells by a macrophage or 2-mercaptoethanol activated serum factor is essential for induction of a primary immune response to heterologous red cells in vitro. Immunol Rev 1978 0.96
25 CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme. J Immunol 2000 0.95
26 An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line. Br J Cancer 1999 0.95
27 High contrast x-ray speckle from atomic-scale order in liquids and glasses. Phys Rev Lett 2012 0.94
28 Single shot speckle and coherence analysis of the hard X-ray free electron laser LCLS. Opt Express 2013 0.94
29 Polyclonal stimulation of lymphocytes by macrophages. Eur J Immunol 1976 0.94
30 Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4). Int J Cancer 1995 0.92
31 Molecular cloning and characterization of human kinectin. Mol Biol Cell 1995 0.90
32 Rapid and simple purification of PCR products by direct band elution during agarose gel electrophoresis. Biotechniques 1993 0.90
33 Cerebrovascular reactivity over time course in healthy subjects. J Neurol Sci 2006 0.89
34 Mycoplasma infection of cell lines can simulate the expression of Fc receptors by binding of the carbohydrate moiety of antibodies. Eur J Immunol 1985 0.87
35 Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: immunodiagnostic value, monoclonal antibodies and characterization of the target antigen. Neth J Med 1990 0.86
36 The role of fetal calf serum in the primary immune response in vitro. J Exp Med 1977 0.86
37 The Hodgkin-associated Ki-1 antigen exists in an intracellular and a membrane-bound form. Biol Chem Hoppe Seyler 1989 0.86
38 A new phagemid vector for positive selection of recombinants based on a conditionally lethal barnase gene. FEBS Lett 1999 0.86
39 A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines. Int J Cancer 1995 0.85
40 Antigen-independent suppression of the IgE immune response to bee venom phospholipase A2 by maternally derived monoclonal IgG antibodies. Eur J Immunol 1998 0.85
41 Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleus. Am J Pathol 1992 0.83
42 Clustering of antigenic determinants on H-2 molecules. J Immunol 1982 0.82
43 The isolation of thirteen cloned hybrid cell lines secreting mouse strain A derived antibodies with specificity for group A streptococcal carbohydrate. Ann Immunol (Paris) 1978 0.82
44 Final report of the technical requirements for image-guided spine procedures Workshop, April 17-20, 1999, Ellicott City, Maryland, USA. Comput Aided Surg 2000 0.82
45 Cerebrovascular reactivity in depressed patients without vascular risk factors. J Psychiatr Res 2006 0.82
46 Correlation between immune maturation and idiotypic network recognition. Eur J Immunol 1996 0.81
47 Characterization, mapping and partial cDNA sequence of the 57-kD intracellular Ki-1 antigen. Exp Clin Immunogenet 1997 0.80
48 Development of new ricin A-chain immunotoxins with potent anti-tumor effects against human Hodgkin cells in vitro and disseminated Hodgkin tumors in SCID mice using high-affinity monoclonal antibodies directed against the CD30 antigen. Int J Cancer 1995 0.80
49 Protein kinase activity of the intracellular but not of the membrane-associated form of the Ki-1 antigen (CD30). Res Immunol 1990 0.80
50 Genetic analysis of the maternally induced affinity enhancement in the non-Ox1 idiotypic antibody repertoire of the primary immune response to 2-phenyloxazolone. Scand J Immunol 1999 0.80
51 Evidence for the origin of Hodgkin and Sternberg-Reed cells from a newly detected small cell population. Haematol Blood Transfus 1983 0.78
52 Growth regulation of a murine lymphoma cell line by a 2-mercaptoethanol or macrophage-activated serum factor. Eur J Immunol 1977 0.78
53 Allergen IgE-isotype-specific suppression by maternally derived monoclonal anti-IgG-idiotype. Allergy 2009 0.77
54 [Pharmacologic-endocrinological findings in animal experiments with TURISYNCHRON and SUISYNCHROM. 2. Toxicologic findings]. Arch Exp Veterinarmed 1974 0.75
55 [Pharmacologic-endocrinological findings in animal experiments with TURISYNCHRON and SUISYNCHRON. 3. Selected pharmacologic and immunologic findings]. Arch Exp Veterinarmed 1974 0.75
56 Induction of a non-oscillating, long-lasting humoral immune response to an internal network antigen. Int Immunol 1996 0.75
57 Impaired brachial artery endothelial function in young healthy women following an acute painful stimulus. Eur J Appl Physiol 2015 0.75
58 [Studies on the quantitative determination of local tissue lesions due to intramuscular injection of aqueous solutions. VI. On possibilities of application of this method for testing oily and water-soluble solvents]. Exp Pathol (Jena) 1972 0.75
59 Criteria and standardization for biocompatibility. Nephrol Dial Transplant 1994 0.75
60 [Specific toxicity tests with various estratrienes (proceedings)]. Pharmazie 1980 0.75
61 Humoral primary immune response in vitro in a homologous mouse system: replacement of fetal calf serum by a 2-mercaptoethanol or macrophage-activated fraction of mouse serum. J Immunol 1977 0.75
62 [Experience with infusion urography]. Dtsch Gesundheitsw 1968 0.75
63 Controlling the behavior of a profoundly retarded child. Am J Occup Ther 1972 0.75
64 Long term toxicological studies on the progestin STS 557. Exp Clin Endocrinol 1983 0.75
65 Studies on the quantification of local tissue injury following intramuscular injection of aqueous solutions. VIII. The local lesion after application of turimycin in different preparations. Exp Pathol (Jena) 1979 0.75